Global Information
회사소개 | 문의 | 비교리스트

세계의 면역치료제 시장 : 유형, 치료 범위, 최종사용자, 지역별 예측 및 COVID-19의 영향

Global Immunotherapy Drugs Market Size study with COVID-19 Impact, by Type, by Therapeutic Area, by End-User and Regional Forecasts 2020-2027

리서치사 Bizwit Research & Consulting LLP
발행일 2020년 06월 상품 코드 943617
페이지 정보 영문
가격
US $ 4,950 ₩ 5,817,000 Unprintable PDF by E-mail (Single User License)
US $ 6,250 ₩ 7,345,000 Printable PDF by E-mail (Enterprise License)


세계의 면역치료제 시장 : 유형, 치료 범위, 최종사용자, 지역별 예측 및 COVID-19의 영향 Global Immunotherapy Drugs Market Size study with COVID-19 Impact, by Type, by Therapeutic Area, by End-User and Regional Forecasts 2020-2027
발행일 : 2020년 06월 페이지 정보 : 영문

세계의 면역치료제 시장은 2019년에 약 1,468억 달러에 달했습니다. 이 시장은 예측 기간 중(2020-2027년) 11%를 넘는 순조로운 성장률로 확대할 것으로 예측됩니다. 기존의 치료 레지멘보다 증가하고 있는 면역치료제의 채택, 암 및 자가면역·감염증의 유병률 상승, 모노클로널 항체 및 바이오시밀러의 수요 증가는 예측 기간 중 이 시장의 성장 요인입니다. 그러나 타임라인 문제, 부작용, 제조의 복잡성은 시장 성장을 억제하는 주요 요인입니다.

세계의 면역치료제 시장에 대해 조사했으며, 시장 기회 및 동향, 성장요인 및 과제, 유형·치료 범위·최종사용자·지역별 시장 분석, 경쟁 구도, 주요 기업의 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 개요

제2장 시장 정의 및 범위

제3장 시장 역학

  • 시장의 영향 분석

제4장 업계 분석

  • Porter의 산업 분석
  • PEST 분석
  • 투자 채택 모델
  • 애널리스트의 제안·결론

제5장 시장 분석 : 유형별

  • 시장 스냅숏
  • 시장 실적 : 잠재력 분석
  • 시장 추산·예측
  • 하위 부문 분석
    • 모노클로널 항체
    • 체크포인트 저해제
    • 인터페론·인터류킨
    • 기타

제6장 시장 분석 : 치료 범위별

  • 시장 스냅숏
  • 시장 실적 : 잠재력 분석
  • 시장 추산·예측
    • 자가면역질환·염증성 질환
    • 감염증
    • 기타

제7장 시장 분석 : 최종사용자별

  • 시장 스냅숏
  • 시장 실적 : 잠재력 분석
  • 시장 추산·예측
  • 하위 부문 분석
    • 병원
    • 클리닉
    • 기타

제8장 시장 분석 : 지역별

  • 시장 스냅숏
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 기타 지역

제9장 경쟁 정보

  • 주요 시장 전략
  • 기업 개요
    • Roche Holding AG
    • Pfizer Inc.
    • Merck & Co., Inc.
    • Novartis International AG
    • Johnson & Johnson
    • Sanofi S.A.
    • GlaxoSmithKline plc
    • AbbVie Inc.
    • Amgen Inc.
    • C.H. Boehringer Sohn AG & Co.. KG

제10장 조사 프로세스

KSA 20.07.03

LIST OF TABLES

  • TABLE 1. Global Immunotherapy Drugs market, report scope
  • TABLE 2. Global Immunotherapy Drugs market estimates & forecasts by region 2017-2027 (USD Billion)
  • TABLE 3. Global Immunotherapy Drugs market estimates & forecasts by Type 2017-2027 (USD Billion)
  • TABLE 4. Global Immunotherapy Drugs market estimates & forecasts by Therapeutic Area 2017-2027 (USD Billion)
  • TABLE 5. Global Immunotherapy Drugs market estimates & forecasts by End-User 2017-2027 (USD Billion)
  • TABLE 6. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 7. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 8. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 9. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 10. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 11. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 12. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 13. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 14. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 15. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 16. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 17. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 18. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 19. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 20. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 21. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 22. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 23. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 24. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 25. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 26. Global Immunotherapy Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 27. Global Immunotherapy Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 28. U.S. Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 29. U.S. Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 30. U.S. Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 31. U.S. Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 32. Canada Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 33. Canada Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 34. Canada Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 35. Canada Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 36. UK Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 37. UK Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 38. UK Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 39. UK Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 40. Germany Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 41. Germany Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 42. Germany Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 43. Germany Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 44. France Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 45. France Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 46. France Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 47. France Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 48. Spain Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 49. Spain Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 50. Spain Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 51. Spain Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 52. Italy Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 53. Italy Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 54. Italy Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 55. Italy Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 56. ROE Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 57. ROE Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 58. ROE Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 59. ROE Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 60. China Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 61. China Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 62. China Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 63. China Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 64. India Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 65. India Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 66. India Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 67. India Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 68. Japan Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 69. Japan Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 70. Japan Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 71. Japan Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 72. Australia Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 73. Australia Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 74. Australia Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 75. Australia Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 76. South Korea Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 77. South Korea Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 78. South Korea Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 79. South Korea Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 80. ROPAC Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 81. ROPAC Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 82. ROPAC Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 83. ROPAC Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 84. Brazil Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 85. Brazil Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 86. Brazil Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 87. Brazil Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 88. Mexico Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 89. Mexico Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 90. Mexico Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 91. Mexico Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 92. ROLA Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 93. ROLA Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 94. ROLA Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 95. ROLA Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 96. ROW Immunotherapy Drugs market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 97. ROW Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 98. ROW Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 99. ROW Immunotherapy Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 100. List of secondary sources, used in the study of global Immunotherapy Drugs market
  • TABLE 101. List of primary sources, used in the study of global Immunotherapy Drugs market
  • TABLE 102. Years considered for the study
  • TABLE 103. Exchange rates considered

LIST OF FIGURES

  • FIG 1. Global Immunotherapy Drugs market, research methodology
  • FIG 2. Global Immunotherapy Drugs market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Immunotherapy Drugs market, key trends 2019
  • FIG 5. Global Immunotherapy Drugs market, growth prospects 2020-2027
  • FIG 6. Global Immunotherapy Drugs market, porters 5 force model
  • FIG 7. Global Immunotherapy Drugs market, pest analysis
  • FIG 8. Global Immunotherapy Drugs market, value chain analysis
  • FIG 9. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
  • FIG 10. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
  • FIG 11. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
  • FIG 12. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
  • FIG 13. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
  • FIG 14. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
  • FIG 15. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
  • FIG 16. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
  • FIG 17. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
  • FIG 18. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
  • FIG 19. Global Immunotherapy Drugs market by segment, 2017 & 2027 (USD Billion)
  • FIG 20. Global Immunotherapy Drugs market, regional snapshot 2017 & 2027
  • FIG 21. North America Immunotherapy Drugs market 2017 & 2027 (USD Billion)
  • FIG 22. Europe Immunotherapy Drugs market 2017 & 2027 (USD Billion)
  • FIG 23. Asia Pacific Immunotherapy Drugs market 2017 & 2027 (USD Billion)
  • FIG 24. Latin America Immunotherapy Drugs market 2017 & 2027 (USD Billion)
  • FIG 25. Global Immunotherapy Drugs market, company market share analysis (2019)

Title:
Global Immunotherapy Drugs Market Size study with COVID-19 Impact, by Type (Monoclonal Antibodies, Checkpoint Inhibitors, Interferons & Interleukins and Other Immunotherapies), by Therapeutic Area (Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases and Others), by End-User (Hospitals, Clinics and Others) and Regional Forecasts 2020-2027.

Global Immunotherapy Drugs Market is valued approximately USD 146.8 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 11 % over the forecast period 2020-2027. Immunotherapy drugs are used to enhance the immunity of human body, the drug stimulates the immune system of the body and generate an immune response aiding the production of antibodies that are produced against antigen to kill the cancerous or tumor cells. Immunotherapy Drugs is being highly demanded for enhancing the immune system during the coronavirus pandemic across the world. Furthermore, cancer immunotherapy community is poised to contribute to the current fight against COVID-19. The increasing adoption of immunotherapy drugs over conventional treatment regimens, rising prevalence of cancer and autoimmune & infectious diseases and increasing demand for monoclonal antibodies and biosimilars are the few factors responsible for growth of the market over the forecast period. For instance: as per American Cancer Society, more than 15.5 million cancer cases were reported in January 2016. Later 1.7 million new cases diagnosed in 2018 at U.S. Moreover, the rising advancements in immunotherapy drugs and other strategic alliance by market key players will create a lucrative demand for this market. For instance: in April 2018, Europe based Roche Holdings AG launched monoclonal antibody atezolizumab used for the treatment of small cell lung cancer in India. Whereas, timeline issues, side-effects, and manufacturing complexities are the major factors restraining the growth of global Immunotherapy Drugs market during the forecast period.

The regional analysis of global Immunotherapy Drugs market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world owing to the increasing prevalence of cancer and autoimmune diseases, rising demand for safer cancer therapies, increasing number of approvals from the FDA, and the introduction of favorable reimbursement policies. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027.

Major market player included in this report are:

Roche Holding AG

Pfizer Inc.

Merck & Co., Inc.

Novartis International AG

Johnson & Johnson

Sanofi S.A.

GlaxoSmithKline plc

AbbVie Inc.

Amgen Inc.

C.H. Boehringer Sohn AG & Co.. KG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

by Type:

Monoclonal Antibodies

Checkpoint Inhibitors

Interferons & Interleukins

Other Immunotherapies

by Therapeutic Area:

Cancer

Autoimmune & Inflammatory Diseases

Infectious Diseases

Others

By End-User:

Hospitals

Clinics

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2017, 2018

Base year - 2019

Forecast period - 2020 to 2027

Target Audience of the Global Immunotherapy Drugs Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
    • 1.2.1. Immunotherapy Drugs Market, by Region, 2018-2027 (USD Billion)
    • 1.2.2. Immunotherapy Drugs Market, by Type, 2018-2027 (USD Billion)
    • 1.2.3. Immunotherapy Drugs Market, by Therapeutic Area, 2018-2027 (USD Billion)
    • 1.2.4. Immunotherapy Drugs Market, by End-User, 2018-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Immunotherapy Drugs Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Immunotherapy Drugs Market Dynamics

  • 3.1. Immunotherapy Drugs Market Impact Analysis (2018-2027)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Immunotherapy Drugs Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Immunotherapy Drugs Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Immunotherapy Drugs Market by Type, Performance - Potential Analysis
  • 5.3. Global Immunotherapy Drugs Market Estimates & Forecasts by Type 2017-2027 (USD Billion)
  • 5.4. Immunotherapy Drugs Market, Sub Segment Analysis
    • 5.4.1. Monoclonal Antibodies
    • 5.4.2. Checkpoint Inhibitors
    • 5.4.3. Interferons & Interleukins
    • 5.4.4. Other Immunotherapies

Chapter 6. Global Immunotherapy Drugs Market, by Therapeutic Area

  • 6.1. Market Snapshot
  • 6.2. Global Immunotherapy Drugs Market by Therapeutic Area, Performance - Potential Analysis
  • 6.3. Global Immunotherapy Drugs Market Estimates & Forecasts by Therapeutic Area 2017-2027 (USD Billion)
    • 6.3.1. Cancer
    • 6.3.2. Autoimmune & Inflammatory Diseases
    • 6.3.3. Infectious Diseases
    • 6.3.4. Others

Chapter 7. Global Immunotherapy Drugs Market, by End-User

  • 7.1. Market Snapshot
  • 7.2. Global Immunotherapy Drugs Market by End-User, Performance - Potential Analysis
  • 7.3. Global Immunotherapy Drugs Market Estimates & Forecasts by End-User 2017-2027 (USD Billion)
  • 7.4. Immunotherapy Drugs Market, Sub Segment Analysis
    • 7.4.1. Hospitals
    • 7.4.2. Clinics
    • 7.4.3. Others

Chapter 8. Global Immunotherapy Drugs Market, Regional Analysis

  • 8.1. Immunotherapy Drugs Market, Regional Market Snapshot
  • 8.2. North America Immunotherapy Drugs Market
      • 8.2.1.1. U.S. Immunotherapy Drugs Market
      • 8.2.1.2. Type breakdown estimates & forecasts, 2017-2027
      • 8.2.1.3. Therapeutic Area breakdown estimates & forecasts, 2017-2027
      • 8.2.1.4. End-User breakdown estimates & forecasts, 2017-2027
    • 8.2.2. Canada Immunotherapy Drugs Market
  • 8.3. Europe Immunotherapy Drugs Market Snapshot
    • 8.3.1. U.K. Immunotherapy Drugs Market
    • 8.3.2. Germany Immunotherapy Drugs Market
    • 8.3.3. France Immunotherapy Drugs Market
    • 8.3.4. Spain Immunotherapy Drugs Market
    • 8.3.5. Italy Immunotherapy Drugs Market
    • 8.3.6. Rest of Europe Immunotherapy Drugs Market
  • 8.4. Asia-Pacific Immunotherapy Drugs Market Snapshot
    • 8.4.1. China Immunotherapy Drugs Market
    • 8.4.2. India Immunotherapy Drugs Market
    • 8.4.3. Japan Immunotherapy Drugs Market
    • 8.4.4. Australia Immunotherapy Drugs Market
    • 8.4.5. South Korea Immunotherapy Drugs Market
    • 8.4.6. Rest of Asia Pacific Immunotherapy Drugs Market
  • 8.5. Latin America Immunotherapy Drugs Market Snapshot
    • 8.5.1. Brazil Immunotherapy Drugs Market
    • 8.5.2. Mexico Immunotherapy Drugs Market
  • 8.6. Rest of The World Immunotherapy Drugs Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Roche Holding AG
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Pfizer Inc.
    • 9.2.3. Merck & Co., Inc.
    • 9.2.4. Novartis International AG
    • 9.2.5. Johnson & Johnson
    • 9.2.6. Sanofi S.A.
    • 9.2.7. GlaxoSmithKline plc
    • 9.2.8. AbbVie Inc.
    • 9.2.9. Amgen Inc.
    • 9.2.10. C.H. Boehringer Sohn AG & Co.. KG

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption
Back to Top
전화 문의
F A Q